Elaine was previously Head of Business Development at GRAIL, Inc. where she was a founding employee and implemented the strategy/transactions to execute the business plan, and strategic collaborations with pharma companies involved in its Series B $900M+ financing. Formerly, she was Director of Strategic Partnerships at Illumina. There, she led BD for the Oncology Business Unit, and also executed strategy and transactions/M&A in the fields of Non-Invasive Prenatal Testing and Transplant Medicine. Elaine spent 6 years at Genomic Health, where she focused on product pipeline and global commercial expansion. Elaine has a BS in Biological Sciences and an MS in Management Science & Engineering, both from Stanford University, where she was also a Mayfield Fund Fellow.